Your feedback is vital to us as we continue to increase the quality of our services.
You are here:
Date: 21 October 2020
Respiratory medicine quality indicator
Percentage of asthmatic patients who are discharged on inhaled steroids
What is asthma?
Asthma is a common condition in which the passages which take air from the mouth into the lungs become narrowed, resulting in coughing, breathlessness and wheezing. This narrowing is generally the result of inflammation in the lining of these air passages.
Effective treatment for asthma involves reducing the amount of inflammation in the air passages using anti-inflammatory steroid drugs, administered either through tablets or inhalers.
How is the Trust doing?
|Rolling year to date (February 2019 – January 2019)||95.8%|
|Rolling 2 years (February 2018 – January 2020)||95.5%|
Over 90% of patients with asthma are currently prescribed inhaled steroids on discharge. Performance is very close to the goal of 95%.
Why is this indicator important?
After discharge from hospital following an episode of asthma, most patients will require treatment with steroid inhalers to continue to keep the inflammation under control. Patients should therefore be discharged on inhaled steroids to improve their symptoms and reduce the likelihood of future hospital admissions. However in some situations, inhaled steroids may not be indicated, for example if patients are not able to use inhalers, their asthma is very mild or if the diagnosis is still not certain.
How do we measure this indicator?
All patients discharged from UHB with asthma listed as the main diagnosis in their discharge letter are identified. The Prescribing Information and Communication System (PICS) database is then checked to see if inhaled steroids were included in each patient’s discharge medication.
Information about travelling to, staying at and getting around the hospital.
Jobs at UHB
A great place to work. Learn why.